Irdabisant
N/A
Report date: 2022/11/25 18:08:23
NME
Base Information
Drug NameIrdabisant
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTeva
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesTeva Branded Pharmaceutical Products R&D Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksKEGG